Sustained engagement in HIV care is critical to the success of Option B+ for HIV-infected pregnant women. However, monitoring women’s engagement in care across clinics and over time is challenging due to migration and clinic transfers. Improved strategies to identify and monitor women’s engagement in HIV care across a network of clinics are needed, but have not been pilot tested. We evaluated the feasibility and acceptability of biometric fingerprint scanning to identify women and monitor HIV visit attendance among women in Option B+. Over a 3-month period, we enrolled HIV-infected pregnant women receiving care at two antenatal clinics in Lilongwe, Malawi and monitored their engagement in care using biometric fingerprint scanning and the standard-of-care electronic medical record (EMR) monitoring system. Biometric data was collected by trained research assistants, who uploaded and synced data across study sites daily using wireless internet. We collected data weekly on the biometric scanner performance, reliability, and usability. We assessed the feasibility and acceptability of using biometric fingerprint scanning to record HIV visits during exit interviews with a sample of participants and healthcare workers and by comparing visit concordance between the biometric fingerprint scanning and EMR systems. We enrolled 314 HIV-infected pregnant women and 51 HCWs (n = 365 total participants). The majority of participants felt the biometric fingerprint scanning system was easy to use (64%), required no additional assistance (69%) and met their expectations (76%). No major issues with data security, privacy, or scanner functionality were reported by HIV-infected women or healthcare workers. Of the 542 HIV visits captured during the study period among women in Option B+, 80% were recorded in the biometric fingerprint system versus 51% in the EMR system (PR 1.57, 95% CI 1.43, 1.72, p-value < 0.05). Among HIV-infected pregnant women engaged in HIV care, biometric fingerprint scanning is a feasible and acceptable way to monitor HIV visits and may improve the ability to monitor women’s engagement in HIV care over time and across clinics. Biometric fingerprint scanning should be scaled-up and evaluated as an implementation strategy to support sustained engagement in HIV care for women during the perinatal period.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Electronic medical record
Human immunodeficiency virus
Lost to follow-up
World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: WHO; 2016, Second. http://www.who.int/hiv/pub/arv/arv-2016/en/. Accessed 13 June 2019.
Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet. 2011;378(9787):282–4.
UNAIDS. 90-90-90: treatment for all; 2018. http://www.unaids.org/en/resources/909090. Accessed 5 Jan 2018.
Rollins NC, Essajee SM, Bellare N, Doherty M, Hirnschall GO. Improving retention in care among pregnant women and mothers living with HIV: lessons from INSPIRE and implications for future WHO guidance and monitoring. J Acquir Immune Defic Syndr. 2017;75(Suppl 2):S111–4.
Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2011. https://doi.org/10.1002/14651858.CD003510.pub3.
Tippett Barr BA, van Lettow M, van Oosterhout JJ, Landes M, Shiraishi RW, Amene E, et al. National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis. Lancet HIV. 2018;5(12):e688–95.
Knettel BA, Cichowitz C, Ngocho JS, Knippler ET, Chumba LN, Mmbaga BT, et al. Retention in HIV care during pregnancy and the postpartum period in the option B+ era: systematic review and meta-analysis of studies in Africa. J Acquir Immune Defic Syndr. 2018;77(5):427–38.
Haas AD, Tenthani L, Msukwa MT, Tal K, Jahn A, Gadabu OJ, et al. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi’s option B+ programme: an observational cohort study. Lancet HIV. 2016;3(4):e175–82.
Tenthani L, Haas AD, Tweya H, Jahn A, van Oosterhout JJ, Chimbwandira F, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi. Aids. 2014;28(4):589–98.
Rice B, Boulle A, Baral S, Egger M, Mee P, Fearon E, et al. Strengthening Routine Data Systems To Track the HIV epidemic and guide the response in sub-Saharan Africa. JMIR Public Health Surveill. 2018;4(2):e36.
Bengtson AM, Go V, Kumwenda W, Lurie M, Kutengule A, Owino M, et al. “A way of escaping”: a qualitative study exploring reasons for clinic transferring and its impact on engagement in care among women in Option B+. AIDS Care. 2019. https://doi.org/10.1080/09540121.2019.1614521.
Tweya H, Gugsa S, Hosseinipour M, Speight C, Ng’ambi W, Bokosi M, et al. Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi. Trop Med Int Health. 2014;19(11):1360–6.
Haas AD, Zaniewski E, Anderegg N, Ford N, Fox MP, Vinikoor M, et al. Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes. J Int AIDS Soc. 2018;21(2):e25084.
Zurcher K, Mooser A, Anderegg N, Tymejczyk O, Couvillon MJ, Nash D, et al. Outcomes of HIV-positive patients lost to follow-up in African treatment programmes. Trop Med Int Health. 2017;22(4):375–87.
World Health Organization. Consolidated guidelines on person-centred HIV patient monitoring and case surveillance. Geneva: World Health Organization; 2017.
Wall KM, Kilembe W, Inambao M, Chen YN, McHoongo M, Kimaru L, et al. Implementation of an electronic fingerprint-linked data collection system: a feasibility and acceptability study among Zambian female sex workers. Glob Health. 2015;11(1):27.
Odei-Lartey EO, Boateng D, Danso S, Kwarteng A, Abokyi L, Amenga-Etego S, et al. The application of a biometric identification technique for linking community and hospital data in rural Ghana. Global Health Action. 2016;9:29854.
Group TSS. Using a fingerprint recognition system in a vaccine trial to avoid misclassification. Bull World Health Organ. 2007;85(1):64–7.
Serwaa-Bonsu A, Herbst AJ, Reniers G, Ijaa W, Clark B, Kabudula C, et al. First experiences in the implementation of biometric technology to link data from Health and Demographic Surveillance Systems with health facility data. Glob Health Action. 2010;3:2120.
Malawi Ministroy of Health. Malawi guidelines for clinical management of HIV in children and adults. Lilongwe; 2016.
Chagomerana MB, Miller WC, Tang JH, Hoffman IF, Harrington BJ, DiPrete B, et al. Prevalence of antiretroviral therapy treatment failure among HIV-infected pregnant women at first antenatal care: PMTCT Option B+ in Malawi. PLoS ONE. 2018;13(12):e0209052.
van Lettow M, Bedell R, Mayuni I, Mateyu G, Landes M, Chan AK, et al. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+). J Int AIDS Soc. 2014;17:18994.
Tweya H, Oboho IK, Gugsa ST, Phiri S, Rambiki E, Banda R, et al. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi. PLoS ONE. 2018;13(1):e0188488.
Storisteanu DM, Norman TL, Grigore A, Norman TL. Biometric fingerprint system to enable rapid and accurate identification of beneficiaries. Global Health Sci Pract. 2015;3(1):135–7.
Clouse K, Vermund SH, Maskew M, Lurie MN, MacLeod W, Malete G, et al. Mobility and clinic switching among postpartum women considered lost to HIV care in South Africa. J Acquir Immune Defic Syndr. 2017;74(4):383–9.
The authors thank Phindile Simelane for her assistance with study coordination. We also thank the funders for their support of this project.
This work was supported by the National Institute of Mental Health [Grant Number R00MH112413] and the University of North Carolina at Chapel Hill Center for AIDS Research, funded by the National Institute of Allergy and Infectious Diseases (Grant number P30 AI50410). The funders did not have any role in the design of the study and collection, analysis, and interpretation of data or in writing the manuscript.
The authors declare that they have no competing interests.
Ethics Approval and Consent to Participate
All participants provided written informed consent and ethical approval was provided by the University of North Carolina (study number 17-1909) in the United States and the National Health Science Research Committee in Malawi (protocol 17/07/1868).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Bengtson, A.M., Kumwenda, W., Lurie, M. et al. Improving Monitoring of Engagement in HIV Care for Women in Option B+: A Pilot Test of Biometric Fingerprint Scanning in Lilongwe, Malawi. AIDS Behav 24, 551–559 (2020). https://doi.org/10.1007/s10461-019-02748-6
- Biometric fingerprint scanning
- Engagement in HIV care
- Feasibility and acceptability